JANUARY 29, 2026, WINTER PARK, FL – Harbor View Advisors is pleased to announce that our client, Conquest Research, LLC (“Conquest”), a portfolio company of Reynolda Equity Partners (“Reynolda”), acquired NeuroTrials Research (“NeuroTrials”).
Headquartered in Winter Park, FL, Conquest is a clinical trial site network with expertise in neurology, orthopedics, rheumatology, pain, cardiometabolics, internal medicine, and other critical therapeutic areas. Conquest's Founder & CEO Mark Daley and CMO Dr. Anand Patel lead a team of experienced Principal Investigators serving global pharmaceutical companies, biotechs and CROs, with a track record of growth across multiple therapeutic indications.
Based in Atlanta, GA, NeuroTrials is a multi-specialty focused clinical research center that works with international pharmaceutical and device companies. NeuroTrials has developed clinical expertise across arange of select therapeutic areas with a particular emphasis on neurological diseases including Alzheimer’s Disease and sleep disorders including OSA, insomnia and narcolepsy. Founded in 1997 by Dr. Russell Rosenberg, NeuroTrialsis currently led by two Principal Investigators, Dr. Michael Lacey and Dr. Matthews Gwynn, who will continue to guide the operation moving forward.
Harbor View served as the advisor to Conquest Research.
About Harbor View Advisors
Harbor View Advisors provides buy-side and sell-side M&A advisory to innovative companies. Our unique approach combines the execution expertise of an investment bank with the strategic thinking of a management consulting firm to work with clients and their teams to achieve their goals.
Acquired
